Vor Biopharma Inc.
NASDAQ:VOR
0.16 (USD) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 81.949 | 31.36 | 57.706 | 119.801 | 48.539 | 6.466 | 0.929 |
| Short Term Investments
| 9.977 | 105.815 | 172.539 | 87.668 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 91.926 | 137.175 | 230.245 | 207.469 | 48.539 | 6.466 | 0.929 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 0.38 | 3.628 | 6.705 | 6.93 | 0.567 | 1.073 | 0.007 |
| Total Current Assets
| 96.507 | 140.803 | 236.95 | 214.399 | 49.106 | 7.539 | 0.936 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 41.588 | 50.098 | 57.078 | 22.523 | 21.845 | 0.728 | 0.071 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 2.413 | 2.413 | 1.559 | 1.559 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 4.796 | 7.225 | 2.925 | 3.255 | 3.398 | 0 | 0 |
| Total Non-Current Assets
| 46.384 | 57.323 | 62.416 | 28.191 | 26.802 | 2.287 | 0.071 |
| Total Assets
| 142.891 | 198.126 | 299.366 | 242.59 | 75.908 | 9.826 | 1.007 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 1.505 | 0.815 | 1.772 | 1.545 | 2.361 | 0.693 | 0.038 |
| Short Term Debt
| 4.215 | 3.83 | 6.544 | 3.678 | 1.726 | 0 | 4.459 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 6.335 | 6.26 | 0 | 1.404 |
| Other Current Liabilities
| 12.892 | 10.927 | 4.803 | 4.93 | 6.12 | 1.493 | 3.277 |
| Total Current Liabilities
| 18.612 | 15.572 | 13.119 | 10.153 | 10.207 | 2.186 | 7.774 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 0 | 31.83 | 71.28 | 32.348 | 34.86 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | -35.64 | -16.174 | -17.43 | 0 | 0 |
| Total Non-Current Liabilities
| 27.615 | 31.83 | 35.64 | 16.174 | 17.43 | 0 | 0 |
| Total Liabilities
| 46.227 | 47.402 | 48.759 | 26.327 | 27.637 | 2.186 | 7.774 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 242.59 | 107.336 | 25.069 | 0.002 |
| Common Stock
| 0.013 | 0.007 | 0.007 | 0.004 | 0.001 | 0 | 0 |
| Retained Earnings
| -456.994 | -340.08 | -222.217 | -130.123 | -61.224 | -17.887 | -7.048 |
| Accumulated Other Comprehensive Income/Loss
| 0.022 | -0.077 | -0.77 | -242.59 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 553.623 | 490.874 | 473.587 | 346.382 | 2.158 | 0.458 | 0.279 |
| Total Shareholders Equity
| 96.664 | 150.724 | 250.607 | 216.263 | 48.271 | 7.64 | -6.767 |
| Total Equity
| 96.664 | 150.724 | 250.607 | 216.263 | 48.271 | 7.64 | -6.767 |
| Total Liabilities & Shareholders Equity
| 142.891 | 198.126 | 299.366 | 242.59 | 75.908 | 9.826 | 1.007 |